The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1537
Antiviral Drugs for Seasonal Influenza 2017-2018
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Antiviral drugs can be used for treatment and prophylaxis of influenza. Frequently updated information on influenza activity, testing for influenza, and antiviral resistance is available from the CDC at www.cdc.gov/flu.

RECOMMENDATIONS FOR TREATMENT — The CDC recommends starting antiviral treatment as soon as possible after illness onset, without waiting for the results of influenza testing.

Antiviral treatment is recommended for all persons with suspected or confirmed influenza who have severe, complicated, or progressive illness, require hospitalization, or are at higher risk for complications, including children <5 years old (especially those <2 years old), persons <19 years old receiving long-term aspirin therapy, adults ≥65 years old, morbidly obese persons (BMI ≥40), women who are pregnant or ≤2 weeks postpartum, persons of ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Antiviral Drugs for Seasonal Influenza 2017-2018
Article code: 1537a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian